0,820  0,003  5 Hydroxytryptamine release stimulant
0,714  0,008  Anxiolytic
0,708  0,009  Mood disorders treatment
0,700  0,009  Antidepressant
0,671  0,003  Tyrosine 3 hydroxylase inhibitor
0,624  0,005  GABA C receptor rho-3 antagonist
0,612  0,005  Psychostimulant
0,590  0,004  5 Hydroxytryptamine 2B antagonist
0,599  0,013  CYP2D6 substrate
0,589  0,005  5 Hydroxytryptamine antagonist
0,581  0,003  5 Hydroxytryptamine 5A antagonist
0,578  0,017  Antipsychotic
0,562  0,005  Antimigraine
0,558  0,003  5 Hydroxytryptamine 5 antagonist
0,538  0,005  5 Hydroxytryptamine 2 antagonist
0,531  0,022  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,512  0,004  5 Hydroxytryptamine 2C antagonist
0,520  0,026  Cognition disorders treatment
0,507  0,026  Vasodilator, peripheral
0,476  0,003  5 Hydroxytryptamine 1D antagonist
0,475  0,006  FMO3 substrate
0,456  0,005  5 Hydroxytryptamine 1 agonist
0,456  0,005  5 Hydroxytryptamine agonist
0,462  0,011  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,454  0,014  Sedative
0,444  0,005  5 Hydroxytryptamine 2A antagonist
0,472  0,040  Calcium channel L-type activator
0,432  0,012  Flavin-containing monooxygenase substrate
0,419  0,009  Irritable Bowel syndrome treatment
0,448  0,040  Aldehyde oxidase inhibitor
0,411  0,005  Alpha 2b adrenoreceptor antagonist
0,411  0,005  Alpha 2a adrenoreceptor antagonist
0,405  0,003  GABA C receptor rho-2 antagonist
0,396  0,007  Antiparkinsonian, tremor relieving
0,392  0,005  Toll-Like receptor 9 antagonist
0,386  0,007  5 Hydroxytryptamine 1 antagonist
0,395  0,017  Cyclic AMP phosphodiesterase inhibitor
0,430  0,053  Antineoplastic (myeloid leukemia)
0,391  0,016  Antiparkinsonian, rigidity relieving
0,381  0,008  Dopamine antagonist
0,367  0,007  5 Hydroxytryptamine 1E antagonist
0,363  0,005  Alpha 2 adrenoreceptor antagonist
0,410  0,053  Stroke treatment
0,380  0,024  Anticonvulsant
0,381  0,026  Acute neurologic disorders treatment
0,409  0,055  Ulceration
0,372  0,022  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,438  0,089  Caspase 9 stimulant
0,351  0,005  5 Hydroxytryptamine 1F antagonist
0,363  0,021  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,349  0,009  Dopamine D2 antagonist
0,342  0,013  Alpha adrenoreceptor antagonist
0,331  0,005  Alpha 2c adrenoreceptor antagonist
0,373  0,054  FMO1 substrate
0,322  0,005  5 Hydroxytryptamine 7 antagonist
0,361  0,048  CYP1A2 substrate
0,380  0,071  MAP kinase kinase 6 inhibitor
0,389  0,083  Antiparkinsonian
0,341  0,039  Antineoplastic (small cell lung cancer)
0,320  0,019  Pneumotoxic
0,305  0,005  5 Hydroxytryptamine 1B antagonist
0,296  0,005  VEGF expression inhibitor
0,333  0,044  Radiosensitizer
0,319  0,037  Dependence treatment
0,304  0,024  Ca2+/calmodulin-dependent kinase IV inhibitor
0,282  0,005  GABA C receptor antagonist
0,281  0,004  GABA C receptor rho-1 antagonist
0,277  0,004  Poly(ADP-ribose) polymerase inhibitor
0,279  0,008  Alpha 1b adrenoreceptor antagonist
0,329  0,059  Analeptic
0,267  0,004  MAP-kinase-activated kinase inhibitor
0,266  0,004  Poly(ADP-ribose) polymerase 1 inhibitor
0,293  0,033  Muscle relaxant
0,313  0,054  Antihypoxic
0,268  0,011  Toll-Like receptor antagonist
0,274  0,020  Erectile dysfunction treatment
0,261  0,007  Dopamine D1 antagonist
0,280  0,029  Male reproductive disfunction treatment
0,366  0,116  Alzheimer's disease treatment
0,261  0,012  5 Hydroxytryptamine 3E antagonist
0,260  0,011  5 Hydroxytryptamine 1A antagonist
0,262  0,013  Age-related macular degeneration treatment
0,251  0,002  5 Hydroxytryptamine 1D agonist
0,251  0,005  MAP3K9 inhibitor
0,294  0,048  5 Hydroxytryptamine uptake stimulant
0,250  0,007  Protein kinase C gamma inhibitor
0,245  0,004  MAP-kinase-activated kinase 2 inhibitor
0,292  0,051  HERG channel blocker
0,311  0,071  Respiratory analeptic
0,303  0,065  CYP2C19 substrate
0,250  0,013  Death-associated protein kinase 2 inhibitor
0,241  0,006  TRPA1 agonist
0,248  0,015  Alpha 1 adrenoreceptor antagonist
0,235  0,005  Vanilloid agonist
0,233  0,005  Cyclin B3 inhibitor
0,248  0,021  NADPH oxidase inhibitor
0,264  0,037  Antialcoholic
0,235  0,011  Histamine H1 receptor antagonist
0,230  0,009  Dopamine D3 antagonist
0,228  0,009  5 Hydroxytryptamine 3A agonist
0,264  0,046  Antihypotensive
0,218  0,004  5 Hydroxytryptamine 6 antagonist
0,233  0,019  Antiadrenergic
0,230  0,016  Antihistaminic
0,241  0,028  Acetylcholine M1 receptor antagonist
0,220  0,008  5 Hydroxytryptamine 1A agonist
0,262  0,052  MAP-kinase-activated kinase 5 inhibitor
0,227  0,019  Adrenaline antagonist
0,218  0,010  Antiprotozoal (Babesia)
0,231  0,026  Toxic, respiratory center
0,319  0,114  Histamine release inhibitor
0,213  0,010  Antineoplastic alkaloid
0,219  0,017  Histamine antagonist
0,294  0,098  Calcium channel activator
0,201  0,005  Phosphodiesterase XI inhibitor
0,201  0,005  Phosphodiesterase 11A inhibitor
0,228  0,033  Attention deficit/hyperactivity disorder treatment
0,228  0,033  Skeletal muscle relaxant
0,202  0,008  Prolactin inhibitor
0,204  0,011  Protein kinase C zeta inhibitor
0,239  0,045  Neurotrophic factor enhancer
0,199  0,007  Antiviral (Papilloma)
0,219  0,029  Activin receptor-like kinase 2 inhibitor
0,228  0,040  Thrombolytic
0,270  0,083  Spasmolytic
0,245  0,058  Ca2+/calmodulin-dependent protein kinase inhibitor
0,257  0,071  Gastrin inhibitor
0,191  0,005  Dyspepsia treatment
0,188  0,004  Poly(ADP-ribose) polymerase 2 inhibitor
0,251  0,068  Cardiodepressant
0,216  0,036  Antiviral (Ebola)
0,248  0,068  DNA synthesis inhibitor
0,195  0,016  Hearing loss treatment
0,291  0,113  CYP2C9 substrate
0,195  0,017  Alpha 1a adrenoreceptor antagonist
0,184  0,007  GABA receptor antagonist
0,255  0,078  DNA damaging
0,179  0,007  GABA A receptor antagonist
0,176  0,004  5 Hydroxytryptamine 2 agonist
0,255  0,084  Huntington's disease treatment
0,263  0,094  CYP2D6 inhibitor
0,170  0,003  Nicotinic alpha3beta2 receptor antagonist
0,238  0,073  Potassium channel (Voltage-sensitive) blocker
0,202  0,039  CNS active muscle relaxant
0,183  0,021  Menstruation disorders treatment
0,204  0,045  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,161  0,005  Glycine receptor antagonist
0,165  0,009  Phosphodiesterase V inhibitor
0,238  0,083  Superoxide dismutase inhibitor
0,179  0,025  Butyrylcholinesterase inhibitor
0,221  0,068  Amyloid beta aggregation inhibitor
0,171  0,018  Protein kinase C mu inhibitor
0,162  0,008  5 Hydroxytryptamine 3 antagonist
0,213  0,060  Focal adhesion kinase 2 inhibitor
0,208  0,055  UGT1A4 substrate
0,176  0,023  Polo-like kinase-4 inhibitor
0,197  0,045  Aldehyde oxidase substrate
0,161  0,009  Phosphodiesterase 5A inhibitor
0,156  0,006  Dopamine D5 antagonist
0,188  0,038  Cyclin-dependent kinase 7 inhibitor
0,222  0,073  EphB2 antagonist
0,174  0,025  GABA receptor agonist
0,157  0,008  TRPA1 antagonist
0,192  0,045  Contraceptive
0,193  0,049  Cholinergic
0,164  0,020  NMDA receptor antagonist
0,168  0,024  NAT2 substrate
0,158  0,014  Contraceptive male
0,167  0,024  Contraceptive female
0,147  0,005  Protein kinase C beta inhibitor
0,151  0,009  Phosphodiesterase 6D inhibitor
0,166  0,025  Gastritis treatment
0,171  0,030  Ferrochelatase inhibitor
0,288  0,151  Analgesic
0,144  0,008  Protein kinase C eta inhibitor
0,178  0,041  Antifungal enhancer
0,219  0,083  Cytostatic
0,150  0,014  Alpha 1d adrenoreceptor antagonist
0,201  0,066  Sleep disorders treatment
0,240  0,105  Antiepileptic
0,145  0,011  Acetylcholine M4 receptor antagonist
0,138  0,005  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,140  0,007  Narcotic antagonist
0,180  0,049  Cyclin-dependent kinase 3 inhibitor
0,136  0,008  Toll-Like receptor 7 antagonist
0,137  0,010  Benzodiazepine agonist
0,180  0,053  Uterine stimulant
0,130  0,004  5 Hydroxytryptamine 1F agonist
0,168  0,042  Movement disorders treatment
0,130  0,005  5 Hydroxytryptamine 1B agonist
0,254  0,129  CYP3A4 substrate
0,142  0,018  Dopamine D4 antagonist
0,141  0,019  Paget's disease treatment
0,129  0,007  5 Hydroxytryptamine 3 agonist
0,160  0,039  DNA intercalator
0,139  0,018  Histamine N-methyltransferase inhibitor
0,174  0,053  Carcinogenic, group 1
0,159  0,039  MAO A inhibitor
0,123  0,004  5 Hydroxytryptamine 3B antagonist
0,126  0,008  5 Hydroxytryptamine 2A agonist
0,231  0,113  Antineoplastic (colorectal cancer)
0,152  0,037  Ca2+-transporting ATPase inhibitor
0,123  0,009  5 Hydroxytryptamine 3A antagonist
0,222  0,109  Antineoplastic (colon cancer)
0,127  0,014  Nicotinic alpha4beta2 receptor antagonist
0,123  0,011  Phosphodiesterase VI inhibitor
0,120  0,008  CC chemokine 5 receptor agonist
0,158  0,046  Nav1.6 sodium channel blocker
0,198  0,087  Antineoplastic enhancer
0,115  0,004  Kainate receptor 2 antagonist
0,161  0,051  Cyclin-dependent kinase inhibitor
0,135  0,025  Acetylcholine nicotinic antagonist
0,114  0,004  AMPA 4 receptor antagonist
0,146  0,037  Interleukin 8 antagonist
0,114  0,005  5 Hydroxytryptamine 7 agonist
0,215  0,107  Antiprotozoal (Trypanosoma)
0,178  0,070  Sigma receptor agonist
0,188  0,081  Anesthetic general
0,113  0,008  Antidote, organophosphates
0,129  0,025  ALK inhibitor
0,152  0,049  Pregnane X receptor agonist
0,260  0,157  15-Lipoxygenase inhibitor
0,109  0,007  5 Hydroxytryptamine 2C agonist
0,140  0,038  Photosensitizer
0,119  0,018  Neuronal nicotinic receptor antagonist
0,189  0,089  MAP kinase kinase 2 inhibitor
0,148  0,047  Antismoking
0,151  0,052  Cocaine dependence treatment
0,121  0,023  Tocolytic
0,151  0,052  Cholinergic antagonist
0,105  0,008  Toll-Like receptor 8 antagonist
0,204  0,107  Antiviral (West Nile virus)
0,149  0,052  Aurora-C kinase inhibitor
0,156  0,059  SULT1A3 substrate
0,114  0,018  Female sexual dysfunction treatment
0,141  0,045  Topoisomerase I inhibitor
0,147  0,051  Acetylcholine antagonist
0,163  0,067  Cyclin-dependent kinase 8 inhibitor
0,192  0,098  ErbB-1 antagonist
0,117  0,022  Alpha adrenoreceptor agonist
0,108  0,015  Alpha 1 adrenoreceptor agonist
0,209  0,116  Radioprotector
0,102  0,011  Cyclin B1 inhibitor
0,099  0,008  Cyclin D1 inhibitor
0,257  0,166  CYP2C19 inhibitor
0,227  0,136  GST M1-1 substrate
0,140  0,050  Acetylcholine muscarinic antagonist
0,166  0,076  ATPase inhibitor
0,118  0,028  Phosphodiesterase I inhibitor
0,098  0,009  Cyclin B2 inhibitor
0,098  0,009  Histamine agonist
0,127  0,039  Chronic obstructive bronchitis treatment
0,136  0,048  Cyclin-dependent kinase 5 inhibitor
0,205  0,118  Antineoplastic (sarcoma)
0,093  0,006  Glutamate (mGluR1a) antagonist
0,122  0,036  Acetylcholine agonist
0,095  0,009  Antihemophilic
0,134  0,048  Aurora-A kinase inhibitor
0,090  0,004  Acid-sensing ion channel blocker
0,105  0,020  Protein kinase C alpha inhibitor
0,195  0,111  Cardiovascular analeptic
0,162  0,078  Prostatic (benign) hyperplasia treatment
0,136  0,053  Antiprotozoal (Amoeba)
0,094  0,011  Cyclin B inhibitor
0,098  0,015  MAP kinase kinase 7 inhibitor
0,137  0,054  Vanilloid 1 agonist
0,174  0,092  Death-associated protein kinase 3 inhibitor
0,119  0,037  Protein kinase C delta inhibitor
0,084  0,003  Imidazoline I1 receptor antagonist
0,129  0,048  Falcipain 3 inhibitor
0,182  0,102  Antiulcerative
0,100  0,020  Acetylcholine M5 receptor agonist
0,110  0,030  Glutamate release inhibitor
0,152  0,072  Pulmonary hypertension treatment
0,141  0,061  Acetylcholinesterase inhibitor
0,092  0,014  AMPA receptor antagonist
0,094  0,017  Alpha 2 adrenoreceptor agonist
0,089  0,013  Phosphodiesterase 1A inhibitor
0,102  0,026  Cyclin-dependent kinase 4 inhibitor
0,130  0,054  DNA repair enzyme inhibitor
0,160  0,084  Catenin beta inhibitor
0,107  0,033  Bromodomain-containing protein 2 inhibitor
0,089  0,015  Cyclin-dependent kinase 6 inhibitor
0,146  0,072  Protein kinase C nu inhibitor
0,104  0,031  Histamine H2 receptor antagonist
0,202  0,129  Antineurogenic pain
0,149  0,076  Raynaud's phenomenon treatment
0,099  0,027  5 Hydroxytryptamine uptake inhibitor
0,137  0,065  Death-associated protein kinase 1 inhibitor
0,154  0,082  Antihelmintic (Nematodes)
0,121  0,049  GABA C receptor agonist
0,104  0,034  GABA A receptor agonist
0,133  0,063  Glutamate receptor antagonist
0,144  0,075  MAP kinase kinase 4 inhibitor
0,227  0,157  Vasodilator, coronary
0,076  0,007  GABA B receptor antagonist
0,090  0,022  Phospholipase D inhibitor
0,141  0,073  Heat shock protein 70 antagonist
0,171  0,103  Antimitotic
0,080  0,013  5 Hydroxytryptamine 4 antagonist
0,115  0,048  Antiemetic
0,115  0,048  Carbonic anhydrase III inhibitor
0,167  0,102  I kappa B kinase epsilon inhibitor
0,085  0,021  Acetylcholine muscarinic agonist
0,068  0,005  Phosphodiesterase 6C inhibitor
0,074  0,011  Histamine H4 receptor antagonist
0,148  0,085  UGT1A3 substrate
0,067  0,005  Kainate receptor 4 antagonist
0,085  0,022  Uterine relaxant
0,085  0,023  Bombesin 1 receptor agonist
0,200  0,140  UGT2B4 substrate
0,176  0,116  Antiprotozoal (Leishmania)
0,079  0,019  Bromodomain-containing protein 4 inhibitor
0,108  0,048  Nitric-oxide synthase inhibitor
0,082  0,023  Acetylcholine M5 receptor antagonist
0,176  0,118  Antiamyloidogenic
0,101  0,043  Restless leg syndrome treatment
0,106  0,049  Tourette's syndrome treatment
0,074  0,017  Prolactin release inhibitor
0,076  0,020  Corticotropin releasing factor 2 receptor antagonist
0,231  0,175  Antineoplastic (endocrine cancer)
0,069  0,013  Kainate receptor antagonist
0,137  0,083  Antiischemic, cerebral
0,208  0,154  Antineoplastic (lung cancer)
0,087  0,033  Dopamine agonist
0,072  0,018  Acetylcholine M1 receptor agonist
0,064  0,010  Benzodiazepine antagonist
0,084  0,031  MAP kinase 7 inhibitor
0,133  0,080  Protein kinase (CK1) inhibitor
0,118  0,066  Aurora-B kinase inhibitor
0,142  0,089  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,055  0,004  5 Hydroxytryptamine 6 agonist
0,067  0,016  Nicotinic receptor alpha3 subunit antagonist
0,266  0,216  MAP kinase 1 inhibitor
0,065  0,015  Potassium channel small-conductance Ca-activated blocker
0,097  0,047  Acetylcholine M3 receptor agonist
0,078  0,028  Aryl hydrocarbon receptor antagonist
0,139  0,090  UGT2B9 substrate
0,066  0,017  Antiviral (Hepatitis D)
0,062  0,014  Kinesin-like protein 1 inhibitor
0,062  0,014  Kinesin antagonist
0,109  0,061  Cyclin-dependent kinase 1 inhibitor
0,065  0,017  NMDA receptor subunit 3B antagonist
0,058  0,010  Somatostatin 5 agonist
0,058  0,010  Histamine H1 receptor agonist
0,071  0,023  Protein kinase C epsilon inhibitor
0,101  0,053  HIV-1 integrase (Overall Integration) inhibitor
0,099  0,051  Alpha 2d adrenoreceptor antagonist
0,078  0,030  Glutamate (mGluR7) antagonist
0,108  0,062  CDC-like kinase 3 inhibitor
0,116  0,070  Autism spectrum disorders treatment
0,052  0,006  Somatostatin 3 antagonist
0,060  0,015  Benzodiazepine inverse agonist
0,050  0,006  Follicle-stimulating hormone agonist
0,173  0,129  Vasodilator
0,080  0,036  Dysmenorrhea treatment
0,052  0,008  AMPA 3 receptor antagonist
0,095  0,051  Antidote, mercury
0,070  0,027  Potassium channel (Ca-activated) blocker
0,050  0,007  Phosphodiesterase 6B inhibitor
0,187  0,144  Amyotrophic lateral sclerosis treatment
0,055  0,013  Alpha 1d adrenoreceptor agonist
0,188  0,146  UGT1A9 substrate
0,088  0,047  Opioid kappa receptor antagonist
0,105  0,064  Cyclin-dependent kinase 2 inhibitor
0,136  0,095  Urinary incontinence treatment
0,088  0,048  Acetylcholine nicotinic agonist
0,064  0,025  Nicotinic receptor alpha7 subunit antagonist
0,111  0,072  Sphingosine 1-phosphate receptor 2 agonist
0,078  0,039  Check point kinase 1 inhibitor
0,135  0,096  MAP kinase 3 inhibitor
0,203  0,165  Transcription factor NF kappa B inhibitor
0,133  0,096  Acute respiratory distress syndrome (ARDS) treatment
0,107  0,070  SULT1A1 substrate
0,069  0,032  CDK4/cyclin D1 inhibitor
0,043  0,006  Protein kinase C beta I inhibitor
0,070  0,034  Adrenaline uptake inhibitor
0,042  0,006  Kainate receptor 5 antagonist
0,044  0,008  Nicotinic alpha3beta4 receptor agonist
0,091  0,056  Gastroesophageal reflux disease treatment
0,132  0,097  Sphingosine 1-phosphate receptor 5 antagonist
0,087  0,053  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,104  0,070  Excitatory amino acid transporter EAAC1 inhibitor
0,107  0,073  Acetylcholine release stimulant
0,044  0,011  Cyclin E2 inhibitor
0,114  0,081  Nav1.3 sodium channel blocker
0,046  0,014  Antiviral (Bovine viral diarrhea virus)
0,100  0,068  Adenylate kinase inhibitor
0,047  0,015  5 Hydroxytryptamine 2B agonist
0,041  0,010  Protein kinase C beta II inhibitor
0,044  0,013  AMPA 1 receptor antagonist
0,081  0,050  NAD(P)H dehydrogenase (quinone) inhibitor
0,039  0,007  Kainate receptor 1 antagonist
0,069  0,037  Hypercalcemia treatment
0,072  0,042  CDC7 inhibitor
0,043  0,014  Acetylcholine M4 receptor agonist
0,035  0,005  Acid ceramidase inhibitor
0,062  0,032  Ryanodine receptor antagonist
0,090  0,061  Polo-like kinase-1 inhibitor
0,110  0,080  Transcription factor STAT6 inhibitor
0,065  0,036  Phosphodiesterase 1B inhibitor
0,058  0,028  Dopamine D4 agonist
0,080  0,050  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,117  0,088  Antihelmintic (Trematoda)
0,063  0,035  Heat shock protein 90 beta antagonist
0,136  0,108  Prostate disorders treatment
0,040  0,012  GHS receptor antagonist
0,173  0,146  RNA-directed DNA polymerase inhibitor
0,032  0,006  Phosphodiesterase 6G inhibitor
0,032  0,006  Phosphodiesterase 6H inhibitor
0,057  0,031  Autotaxin inhibitor
0,095  0,069  Insulin receptor antagonist
0,056  0,030  Sigma receptor antagonist
0,120  0,094  Neurotrophic factor
0,039  0,013  Sigma 2 receptor antagonist
0,050  0,025  Cholecystokinin antagonist
0,064  0,039  NMDA 2C receptor antagonist
0,036  0,011  Nicotinic alpha4beta2 receptor agonist
0,065  0,041  Acetylcholine M2 receptor antagonist
0,066  0,042  Cyclin A2 inhibitor
0,136  0,113  LIM domain kinase 1 inhibitor
0,141  0,118  Antineoplastic (gastric cancer)
0,056  0,033  Lysine-specific demethylase 1A inhibitor
0,073  0,050  Polo-like kinase-2 inhibitor
0,083  0,060  D-Ala-D-Ala ligase inhibitor
0,124  0,102  Genotoxic
0,046  0,024  Nerve growth factor antagonist
0,043  0,021  Protein kinase (CK1) epsilon inhibitor
0,043  0,021  Histone deacetylase 9 inhibitor
0,178  0,156  CYP1A2 inhibitor
0,081  0,060  Inducible nitric-oxide synthase inhibitor
0,106  0,084  MAO inhibitor
0,060  0,038  Dopamine uptake inhibitor
0,042  0,020  Vesicle monoamine transporter inhibitor
0,047  0,025  Histamine H2 receptor agonist
0,045  0,024  CDK5/p25 inhibitor
0,130  0,109  Polo-like kinase-3 inhibitor
0,090  0,069  Toll-Like receptor 3 antagonist
0,026  0,006  Kainate receptor 3 antagonist
0,025  0,005  Follicle-stimulating hormone antagonist
0,085  0,066  Pim-3 kinase inhibitor
0,148  0,128  Abortion inducer
0,043  0,024  Dopamine D5 agonist
0,042  0,024  NMDA receptor subunit 3A antagonist
0,042  0,025  Phenylethanolamine N methyltransferase inhibitor
0,034  0,017  AMPA 2 receptor antagonist
0,144  0,127  UGT1A1 substrate
0,093  0,076  Nav1.1 sodium channel blocker
0,059  0,042  Androgen agonist
0,150  0,133  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,089  0,073  Sphingomyelinase inhibitor
0,086  0,070  SULT1E1 substrate
0,147  0,132  Antirickettsial
0,081  0,067  Opioid antagonist
0,099  0,085  Adenylate cyclase inhibitor
0,044  0,030  Histamine H3 receptor antagonist
0,051  0,039  Melanin-concentrating hormone receptor 1 antagonist
0,058  0,046  Cyclin A inhibitor
0,052  0,041  Myc inhibitor
0,089  0,077  MAP kinase kinase kinase inhibitor
0,122  0,111  UGT2B7 substrate
0,021  0,010  Histamine H4 receptor agonist
0,180  0,169  Antineoplastic (bladder cancer)
0,024  0,014  Phosphodiesterase 6A inhibitor
0,152  0,142  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,107  0,097  Glycogen synthase kinase-3 alpha inhibitor
0,051  0,041  Dipeptidyl peptidase inhibitor
0,052  0,042  Pim-2 kinase inhibitor
0,070  0,061  Analgesic, opioid
0,082  0,074  Sodium/hydrogen exchanger 5 inhibitor
0,047  0,038  Bombesin 2 receptor antagonist
0,086  0,078  Creatine kinase inhibitor
0,016  0,009  CXC chemokine 4 receptor agonist
0,060  0,053  Histone deacetylase inhibitor
0,078  0,071  CDK/cyclin complex inhibitor
0,035  0,028  Histone deacetylase 7 inhibitor
0,081  0,074  Potassium channel activator
0,055  0,048  Acetylcholine M3 receptor antagonist
0,162  0,156  Interleukin agonist
0,052  0,046  Glutamate (mGluR1) antagonist
0,053  0,047  Protein kinase C theta inhibitor
0,060  0,055  Beta 3 adrenoreceptor antagonist
0,051  0,045  Bruton tyrosine kinase inhibitor
0,136  0,131  UGT2B10 substrate
0,046  0,041  Nicotinic receptor alpha4 subunit antagonist
0,032  0,028  Benzodiazepine receptor peripheral-type antagonist
0,173  0,168  Prostate cancer treatment
0,050  0,046  Nicotinic neuronal receptor agonist
0,068  0,065  Focal adhesion kinase 1 inhibitor
0,051  0,047  Epithelial sodium channel blocker
0,085  0,082  Dementia treatment
0,075  0,072  Androgen antagonist
0,085  0,082  Posttraumatic stress disorder treatment
0,061  0,058  Sirtuin 1 inhibitor
0,054  0,051  Opioid delta receptor antagonist
0,083  0,080  Vascular dementia treatment
0,102  0,099  Alpha-N-acetylglucosaminidase inhibitor
0,029  0,027  Vasopressin 2 antagonist
0,052  0,051  CDK4/cyclin D inhibitor
0,054  0,052  Cyclin A1 inhibitor
0,122  0,121  Adenylate cyclase stimulant
0,076  0,076  Sleep apnea treatment
0,179  0,179  Hypoxia-inducible factor 1 alpha inhibitor
0,026  0,026  Estrogen-related receptor gamma antagonist
0,210  0,210  Antiprotozoal

